BY Bryan Tutt

Patients with recurrent or second primary head and neck cancer who previously received radiation therapy to the head and neck region – especially those with unresectable tumors – have typically had a dismal prognosis and limited treatment options.

Although radiation therapy offers high rates of local disease control, re-irradiating the region is usually avoided for fear of damaging previously irradiated healthy tissue, including...

stereotactic body radiation therapy